Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-26

Clinical Trial Update: Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia [Phase 2]

View source ↗

Summary

Phase 2 trial examining long-term outcomes of N-Carbamylglutamate in Propionic Acidemia and Methylmalonic Acidemia; the study was terminated but results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-Carbamylglutamate (N-carbamylglutamate)

Snippet

Sponsor: Mendel Tuchman | Conditions: Propionic Acidemia, Methylmalonic Acidemia | Phase 2 | Status: TERMINATED | Results posted: 2017-04-26